Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-21-011766

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Mar 31, 2021 42.96M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $89.43K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $118.61K
Total Liabilities Q1 2021 · Mar 31, 2021 $10.33K
Total Liabilities Q1 2021 · Dec 31, 2020 $14.76K
Total Assets Q1 2021 · Mar 31, 2021 $89.94K
Total Assets Q1 2021 · Dec 31, 2020 $118.61K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$20.71K
Stockholders Equity Q1 2021 · Mar 31, 2020 $204.79K
Stockholders Equity Q1 2021 · Dec 31, 2019 $234.91K
Sga Expense Q1 2021 · Mar 31, 2020 $45.13K
Net Income Q1 2021 · Mar 31, 2020 −$30.12K
Operating Income Q1 2021 · Mar 31, 2020 −$30.13K
Revenue Q1 2021 · Mar 31, 2020 $15K